Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:IRMD NASDAQ:PLSE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$2.79-2.1%$3.64$1.04▼$4.50$119.21M1.35139,162 shs278,091 shsIRMDiRadimed$85.86+1.1%$96.34$50.31▼$107.90$1.10B0.9187,850 shs115,958 shsPLSEPulse Biosciences$18.65-6.9%$20.85$12.56▼$26.30$1.27B1.63314,616 shs366,438 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical0.00%-18.62%-16.85%-30.30%+144.80%IRMDiRadimed0.00%-2.17%-9.44%-11.05%+62.99%PLSEPulse Biosciences0.00%-8.04%-9.43%+48.36%+21.18%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$2.79-2.1%$3.64$1.04▼$4.50$119.21M1.35139,162 shs278,091 shsIRMDiRadimed$85.86+1.1%$96.34$50.31▼$107.90$1.10B0.9187,850 shs115,958 shsPLSEPulse Biosciences$18.65-6.9%$20.85$12.56▼$26.30$1.27B1.63314,616 shs366,438 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical0.00%-18.62%-16.85%-30.30%+144.80%IRMDiRadimed0.00%-2.17%-9.44%-11.05%+62.99%PLSEPulse Biosciences0.00%-8.04%-9.43%+48.36%+21.18%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate Buy$6.50132.97% UpsideIRMDiRadimed 3.00Buy$120.0039.76% UpsidePLSEPulse Biosciences 2.33Hold$30.0060.86% UpsideCurrent Analyst Ratings BreakdownLatest IRMD, PLSE, and APYX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2026PLSEPulse Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/2/2026IRMDiRadimed Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy3/27/2026APYXApyx Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/11/2026APYXApyx Medical Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$5.00 ➝ $6.003/11/2026APYXApyx Medical BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$6.002/20/2026PLSEPulse Biosciences OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$30.002/11/2026IRMDiRadimed Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$120.002/10/2026IRMDiRadimed Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$120.002/6/2026PLSEPulse Biosciences MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$30.00(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$52.84M2.21N/AN/A$0.39 per share7.15IRMDiRadimed$86.28M12.72$1.83 per share46.88$7.44 per share11.54PLSEPulse Biosciences$350K3,622.84N/AN/A$1.19 per share15.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$11.21M-$0.27N/AN/AN/A-21.22%-114.95%-18.49%5/7/2026 (Estimated)IRMDiRadimed$22.48M$1.8346.9239.75N/A27.36%24.66%21.47%N/APLSEPulse Biosciences-$72.78M-$1.08N/AN/AN/AN/A-73.77%-63.98%5/7/2026 (Estimated)Latest IRMD, PLSE, and APYX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026APYXApyx Medical-$0.11N/AN/AN/A$10.78 millionN/A5/4/2026Q1 2026PLSEPulse Biosciences-$0.27-$0.27N/A-$0.27$0.25 million$0.40 million5/1/2026Q1 2026IRMDiRadimed$0.46$0.49+$0.03$0.45$21.32 million$21.98 million3/10/2026Q4 2025APYXApyx Medical-$0.06-$0.03+$0.03-$0.03$19.12 million$19.16 million2/19/2026Q4 2025PLSEPulse Biosciences-$0.32-$0.26+$0.06-$0.26$0.23 millionN/A2/10/2026Q4 2025IRMDiRadimed$0.49$0.54+$0.05$0.50$21.60 million$22.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/AIRMDiRadimed$0.800.93%N/A43.72%1 YearsPLSEPulse BiosciencesN/AN/AN/AN/AN/ALatest IRMD, PLSE, and APYX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2026IRMDiRadimedquarterly$0.200.92%5/15/20265/15/20265/29/20262/9/2026IRMDiRadimedquarterly$0.200.79%2/23/20262/23/20263/6/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical2.355.004.26IRMDiRadimedN/A7.986.84PLSEPulse BiosciencesN/A10.5310.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%IRMDiRadimed92.34%PLSEPulse Biosciences76.95%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%IRMDiRadimed36.80%PLSEPulse Biosciences74.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27041.83 million35.47 millionOptionableIRMDiRadimed11012.78 million8.08 millionOptionablePLSEPulse Biosciences14067.99 million17.27 millionOptionableIRMD, PLSE, and APYX HeadlinesRecent News About These CompaniesPulse Biosciences Reports Business Updates and First Quarter 2026 Financial ResultsMay 4 at 10:18 PM | finance.yahoo.comPulse Biosciences (PLSE) Q1 2025 Earnings TranscriptMay 4 at 10:18 PM | fool.comPulse Biosciences (NASDAQ:PLSE) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPSMay 4 at 9:22 AM | marketbeat.comPulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue EstimatesMay 4 at 9:06 AM | zacks.comPulse Biosciences (PLSE) Expected to Announce Quarterly Earnings on ThursdayApril 30, 2026 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Shares Down 7.9% - What's Next?April 29, 2026 | marketbeat.comPulse Biosciences, Inc. (PLSE) Shareholder/Analyst Call - SlideshowApril 27, 2026 | seekingalpha.comPulse Biosciences has positive PFA data at HRS 2026April 25, 2026 | massdevice.comPulse Biosciences, Inc. (PLSE) Shareholder/Analyst Call TranscriptApril 25, 2026 | seekingalpha.comPulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026April 25, 2026 | businesswire.comPulse Biosciences Trials And Conference Spotlight Reframe Pulse Field Ablation StoryApril 24, 2026 | finance.yahoo.comPulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation TrialApril 20, 2026 | insidermonkey.comPulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual MeetingApril 20, 2026 | timesargus.comTPulse Biosciences' nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual MeetingApril 20, 2026 | businesswire.comPulse Biosciences to Host Analyst Event on April 25, 2026April 18, 2026 | finance.yahoo.comPulse Biosciences (NASDAQ:PLSE) Trading 10.1% Higher - Here's WhyApril 17, 2026 | marketbeat.comPulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF StudyApril 13, 2026 | zacks.comCan Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy?April 13, 2026 | finance.yahoo.comPulse Biosciences names Liane Teplitsky as new COOApril 9, 2026 | massdevice.comPulse Biosciences Strengthens Executive Leadership TeamApril 9, 2026 | finance.yahoo.comPulse Biosciences: Promising Catheter Technology, Weak Risk-Reward For NowApril 8, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIRMD, PLSE, and APYX Company DescriptionsApyx Medical NASDAQ:APYX$2.79 -0.06 (-2.11%) Closing price 04:00 PM EasternExtended Trading$2.83 +0.04 (+1.43%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.iRadimed NASDAQ:IRMD$85.86 +0.94 (+1.11%) Closing price 04:00 PM EasternExtended Trading$85.95 +0.09 (+0.10%) As of 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Pulse Biosciences NASDAQ:PLSE$18.65 -1.38 (-6.89%) Closing price 04:00 PM EasternExtended Trading$18.64 -0.01 (-0.05%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
